Daniel J. Brennan - 18 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: EVP and CFO
Issuer ticker: BSX
Reported as of: 18 Feb 2025
Net transaction value: -$7,369,021
SEC form: 4
Accepted by SEC: 19 Feb 2025, 16:23:45 UTC
Prior SEC filing: 18 Feb 2025
Next SEC filing: 05 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Susan Thompson, Attorney-in-Fact

Key filing fact

Daniel J. Brennan filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 19 Feb 2025.

Key facts

This page summarizes Daniel J. Brennan's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
11 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 19 Feb 2025, 16:23.

Change

Previous filing in this sequence was filed on 18 Feb 2025.
Current net transaction value: -$7,369,021.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Sale

Transaction value: $301,818
Shares: -2,900
Change %: -1.2%
Price: $104.08
Shares after: 247,248
Date: 18 Feb 2025
Ownership: Direct
Footnotes: F1, F2

BSX transaction

Common Stock

Sale

Transaction value: $1,531,366
Shares: -14,630
Change %: -5.9%
Price: $104.67
Shares after: 232,618
Date: 18 Feb 2025
Ownership: Direct
Footnotes: F1, F3

BSX transaction

Common Stock

Options Exercise

Transaction value: $454,985
Shares: +18,533
Change %: +8%
Price: $24.55
Shares after: 251,151
Date: 19 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Options Exercise

Transaction value: $291,090
Shares: +16,865
Change %: +6.7%
Price: $17.26
Shares after: 268,016
Date: 19 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Options Exercise

Transaction value: $423,742
Shares: +15,642
Change %: +5.8%
Price: $27.09
Shares after: 283,658
Date: 19 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Options Exercise

Transaction value: $380,458
Shares: +9,483
Change %: +3.3%
Price: $40.12
Shares after: 293,141
Date: 19 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Sale

Transaction value: $7,086,111
Shares: -67,333
Change %: -23%
Price: $105.24
Shares after: 225,808
Date: 19 Feb 2025
Ownership: Direct
Footnotes: F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -15,642
Change %: -33%
Price: $0.000000
Shares after: 31,285
Date: 19 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,642
Exercise price: $27.09
Footnotes: F1, F5

BSX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -9,483
Change %: -20%
Price: $0.000000
Shares after: 37,934
Date: 19 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,483
Exercise price: $40.12
Footnotes: F1, F6

BSX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -16,865
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,865
Exercise price: $17.26
Footnotes: F1, F7

BSX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -18,533
Change %: -33%
Price: $0.000000
Shares after: 37,067
Date: 19 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,533
Exercise price: $24.55
Footnotes: F1, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024.

Footnote F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.35 to $104.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.37 to $105.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F4

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.46, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F5

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.

Footnote F6

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

Footnote F7

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Footnote F8

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.